Michael T. Kidd

OverviewAI-generated summary

Michael T. Kidd's research focuses on the development and validation of diagnostic techniques, particularly for infectious diseases and cancer. His work has investigated the accuracy of various molecular diagnostic platforms, including loop-mediated isothermal amplification (LAMP) coupled with nanopore sequencing, and reverse-transcription LAMP for the detection of SARS-CoV-2 in different sample types. He has also contributed to studies evaluating the sensitivity of lateral flow tests for asymptomatic SARS-CoV-2 detection and the association of viral load with specific SARS-CoV-2 variants.

Beyond infectious diseases, Kidd has explored advancements in cancer diagnostics and treatment. This includes research into multianalyte liquid biopsies for breast cancer workup and participation in clinical trials for ovarian cancer. His publications also encompass guidelines for HIV-2 management and case reports on viral infections, such as vaccine-derived polio virus treated with remdesivir.

Kidd leads a research group and has a substantial publication record, with 123 total publications and 5,640 citations, reflected in his h-index of 37. He has collaborated with researchers at the University of Arkansas at Fayetteville, including Inkar Castellanos.

Metrics

• h-index: 37
• Publications: 123
• Citations: 5,640